Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01973413 · ClinicalTrials.gov registry record · NA

Diabetes Assistant (DiAs) Control-to-Range (CTR) Nocturnal Closed-Loop Camp Study

A NA study of Diabetes Mellitus, Type 1, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT01973413 is a NA study of Diabetes Mellitus, Type 1 that has completed, run by University of Virginia. The registered enrollment target is 32 participants, below the 1,266-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01973413, a NA study of Diabetes Mellitus, Type 1, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

The primary goal is to test the function of the Diabetes Assistant (DiAs) enhanced control-to-range (CTR) controller in a closely monitored diabetes camp setting. The camp setting will allow us to obtain pilot efficacy data.

Conditions Studied

Interventions

  • DEVICE Diabetes Assistant (DiAs)
  • DEVICE Tandem t:slim Insulin Pump
  • DEVICE Dexcom G4 Platinum sensor

Study Locations (1)

California

  • Stanford University - Los Gatos

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2013-07
Est. Completion 2013-08
Phase NA

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT01973413

The ClinicalTrials.gov registry entry for NCT01973413 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,266-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (97% lower). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus, Type 1 appearing as the primary indexed condition, and to 3 interventions - of which Diabetes Assistant (DiAs) is the first listed.

NCT01973413 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01973413 about?

NCT01973413 is a clinical study titled "Diabetes Assistant (DiAs) Control-to-Range (CTR) Nocturnal Closed-Loop Camp Study". The primary goal is to test the function of the Diabetes Assistant (DiAs) enhanced control-to-range (CTR) controller in a closely monitored diabetes camp setting. The camp setting will allow us to obtain pilot efficacy data.

What is the current status of trial NCT01973413?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2013-07. Estimated completion is 2013-08.

What conditions does trial NCT01973413 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 1.

What interventions are being tested in trial NCT01973413?

The interventions under investigation include: Diabetes Assistant (DiAs) (DEVICE), Tandem t:slim Insulin Pump (DEVICE), Dexcom G4 Platinum sensor (DEVICE).

Who is sponsoring clinical trial NCT01973413?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01973413 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 1

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.